About Karnim
Karnim is a Healthcare company based in Nagpur (India) founded in 1927. It produces and sells herbal products for diabetes management and Ayurvedic formulations. It operates on a D2C and B2C model. The company has 76 employees. Its Indian entity Unijules Life Sciences Limited reported revenue of ₹61.64 Cr. Karnim offers products and services including KARNIM Capsules and AYUSH-64 Tablets. Its focus areas include Pharmaceuticals, Herbal Medicine, Diabetes Supplements and Ayurvedic Medicine. Its competitors include Kapiva, Setu and BBetter; 3 of its 3 listed competitors have raised funding.
Company details
Unijules Life Sciences Ltd. develops and manufactures herbal supplements like KARNIM Capsules and AYUSH-64 Tablets, focusing on diabetes control and antiviral properties through Ayurvedic methods. Based in Kalmeshwar, Nagpur, India, the company enhances drug efficacy via traditional purification techniques and offers products for preventive health. It operates by selling directly online and advises users to consult healthcare providers for proper usage, ensuring accessibility at affordable costs.
- Headquarters Nagpur, India
- Employees 76
- SectorsHealthcare
- Email••••••••
- Website karnim.com
- Social Facebook
- Legal Name Unijules Life Sciences Ltd.
- Date of Incorporation 16 Jan, 2006
- Jurisdiction Nagpur, Maharashtra, India
- Annual Revenue₹61.64 Cr
FY 2018 · -4% YoY
- Net Loss-₹10.68 Cr
FY 2018 · -17% margin
- EBITDA₹3.69 Cr
FY 2018 · 6% margin
- Employee Count76
Associated legal entities of Karnim
Karnim operates through Unijules Life Sciences Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2018) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Unijules Life Sciences Limited CIN U52311MH2006PLC158928 | Active | 16 Jan 2006 | Nagpur, Maharashtra | ₹61.6 Cr | 57 | 3 | View details |
Products & Services of Karnim
Karnim offers a comprehensive portfolio of products and services, including KARNIM Capsules and AYUSH-64 Tablets.
Manages diabetes by improving metabolism and reducing side effects.
Aids in managing malaria and COVID-19 symptoms as an adjunct therapy.
Board of directors of Unijules Life Sciences Limited (Karnim)
Unijules Life Sciences Limited is the primary company behind Karnim. The board of Unijules Life Sciences Limited currently have 3 directors; the longest-serving is Pawan Kumar Chokhani, appointed in 2026. 26 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pawan Kumar Chokhani DIN 00550963 | Director | 01 Jan 2026 | 10 mo | Unijules Life Sciences Limited |
| Pranav Pawan Chokhani DIN 07259400 | Director | 01 Jan 2026 | 10 mo | Unijules Life Sciences Limited |
| Ankit Pawan Chokhani DIN 05208727 | Director | 01 Jan 2026 | 10 mo | Unijules Life Sciences Limited |
Financials of Karnim
Figures of Unijules Life Sciences Limited, the primary company behind Karnim, for FY 2018. Revenue was ₹61.64 Cr (-4% year on year). Net loss was -₹10.68 Cr (-17% margin). EBITDA was ₹3.69 Cr (6% margin). Revenue has grown at a compounded annual rate of -4% over three years.
- ₹61.64 CrRevenue · FY 2018 · -4% YoY
- -₹10.68 CrNet loss · -17% margin
- ₹3.69 CrEBITDA · 6% margin
- ₹1.00 CrPaid-up capital
- 57Employees (provident fund records)
- -4%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Unijules Life Sciences Limited are on its company page.
Detailed financial statements for Karnim
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Karnim
Karnim has 3 listed competitors in our database, 3 of them funded. They include Kapiva, Setu and BBetter.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kapiva.in | 2016 | Bengaluru, India | $77.85M | 492 | Ayurvedic healthcare and nutritional products are provided by Kapiva. | |
| setu.in | 2017 | Mumbai, India | $1.72M | 200 | Dietary supplements with herbal extracts and vitamins are provided. | |
| bbetter.co | 2018 | Hyderabad, India | $1.89M | 151 | Nutritional supplements are provided to enhance health and wellness. |
Detailed competitors of Karnim
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Karnim
Karnim was founded in 1927.
Karnim is headquartered in Nagpur, India. It is registered at Nagpur, Maharashtra, India.
Karnim has 76 employees.
The primary company behind Karnim, Unijules Life Sciences Limited, reported revenue of ₹61.64 Cr for FY 2018, down 4% year on year.
Unijules Life Sciences Ltd. develops and manufactures herbal supplements like KARNIM Capsules and AYUSH-64 Tablets, focusing on diabetes control and antiviral properties through Ayurvedic methods. Based in Kalmeshwar, Nagpur, India, the company enhances drug efficacy via traditional purification techniques and offers products for preventive health. It operates by selling directly online and advises users to consult healthcare providers for proper usage, ensuring accessibility at affordable costs.
Karnim offers KARNIM Capsules and AYUSH-64 Tablets.
Karnim operates through Unijules Life Sciences Limited.
The legal entities of Karnim currently have 3 directors, including Pawan Kumar Chokhani, Pranav Pawan Chokhani, Ankit Pawan Chokhani.